(Q34623074)

3 August 2017

title

Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews (English)

1 reference

3 August 2017

2

Joel Lexchin

1 reference

3 August 2017

Danielle Bishop

1

1 reference

3 August 2017

publication date

9 March 2013

1 reference

BMC Health Services Research

3 August 2017

published in

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

page(s)

88

1 reference

Creative Commons Attribution 2.0 Generic

3 August 2017

copyright license

start time

9 March 2013

1 reference

April 2022 Public Data File from Crossref

Creative Commons Attribution 2.0 Generic

0 references

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Access with evidence development: the US experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Principles of design of access with evidence development approaches: a consensus statement from the Banff Summit

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

The Bosentan Patient Registry: long-term survival in pulmonary arterial hypertension

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Clinical trial for Fabry disease faces continuing hurdles

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Fabry trial set to answer "political problem".

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Enzyme therapy for Fabry patients in jeopardy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: the Bosentan Patient Registry

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Coverage with evidence development: ethical issues and policy implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Relationship between conflicts of interest and research results

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

A cost-effectiveness approach to drug subsidy and pricing in Australia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599546

Coverage with evidence development for pharmaceuticals: a policy in evolution?

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1472-6963-13-88

Evidence-Based Decision Making: When Should We Wait For More Information?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1472-6963-13-88

Coverage with evidence development: an examination of conceptual and policy issues

21 January 2018

1 reference

12 December 2020

We know accurately only when we know little

1 reference

12 December 2020

Commentary: Scheme has benefited patients

1 reference

12 December 2020

Constructing Grounded Theory: A practical guide through qualitative analysis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6963-13-88

1 reference

release_lquhjeunmrbofcaegc5f6zijfe

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lquhjeunmrbofcaegc5f6zijfe

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3599546

1 reference

3 August 2017

1 reference